QIAGEN provides earnings guidance for the third quarter and full year 2021. The company has updated its full-year 2021 outlook for net sales to grow at least 12% CER (prior outlook of about 18-20% CER). For the third quarter of 2021, net sales at CER are expected to be at the same level of sales in third quarter 2020 of about $483.8 million.